Our main findings were that dietary SAAR recapitulates some of these benefits in adult humans with overweight and obesity compared to controls, including decreased body weight, BMI, and serum leptin concentrations, and increased plasma concentrations of the ketone bodies β-hydroxybutyrate and acetoacetate [12–25]. The gene discussed is LEP; the disease is Obesity.